Australia Urged to Simplify Regulatory Framework to Boost Capital Inflows Outgoing Watchdog Says Wingstop Shares Drop 12 as Profit Misses Market Expectations Trump Dismisses Concerns Over Powells Continued Tenure at Federal Reserve Morgan Stanley Raises Price Target on Teradyne TER Amid Semiconductor Testing Demand Sebi Bars Seven Entities for Stock Manipulation via Social Media Freezes 20 Crore Gains Apples RecordBreaking Rally Faces Key Test at WWDC 2025 AI Showcase YETI Q1 2026 Earnings Strong EPS Beat Fuels Investor Optimism Despite Revenue Ambiguity HCC Q1 2026 Earnings EPS Misses Estimates as Operating Costs Pressure Results Dynex Capital DX Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Rate Uncertainty NESR Q1 2026 Earnings Profit Beat Driven by Cost Discipline and Service Demand ACU Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges BFRI Q1 2026 Earnings Wide EPS Miss Fails to Dampen Investor Sentiment Alerus Financial ALRS Edges Lower Amid Modest Pullback Key Support and Resistance Levels in Focus Nutrien NTR Edges Lower Amid Broader Commodity Weakness Support Levels Tested Presidio Property Trust SQFT Faces Pressure Tests Key Support Zone Fortress Biotech FBIO Gains 162 as Shares Approach Key Resistance at 297 Donaldson Company Inc DCI Stock Dips Slightly as Key Support Levels Come into Focus Andy Burnhams Electoral Reform Proposal Could Reshape UK Political Landscape Market Implications Emerge Consumer Sentiment Plunges to Record Low in May Amid Iran Conflict and Inflation Fears Samsungs Latest Labor Deal May Set Precedent for Bonus Negotiations Across South Korean Industries The Fed May Have Fewer Justifications for Rate Cuts CNBC Analysis Suggests Microsoft Anthropic in Talks Over Custom AI Chip Deal Following 5 Billion Investment Medical Technology Stocks in Focus Insider Monkeys Top 11 Picks for Investors Tech Media Telecom Roundup Market Talk Highlights DeepSeek SoFi and Sector Trends Expion360 Inc XPON Q2 2025 Earnings NarrowerThanExpected Loss on Improved Operating Efficiency Jazz Pharmaceuticals JAZZ Shares Dip 132 as Stock Tests Key Support Levels